Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Aitiologic raises €6.4M in oversubscribed seed funding co-led by Heal Capital and Ananda Impact Ventures to advance its tissue-resolved liquid biopsy platform for preeclampsia detection.

PRIVATESep 15, 2026•1 day ago

Amount Raised

$7.4 Million

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Dr. Gordon SangheraAnanda Impact VenturesHeal Capital

Description

Aitiologic, a precision medicine company, closed a €6.4 million (approximately $7.4 million) seed financing round co-led by Heal Capital and Ananda Impact Ventures. The funding will support validation and regulated product development of the Aitios® platform, a multi-modal cell-free DNA platform for first-trimester preeclampsia risk stratification. Dr. Gordon Sanghera, co-founder and former CEO of Oxford Nanopore Technologies, participated as an investor and joined the advisory board

Company Information

Company

Aitiologic

About

Aitiologic is a precision medicine company developing tissue-resolved liquid biopsy solutions that combine genomic, epigenomic and fragmentomic information from circulating cell-free DNA with AI-powered interpretation. The company's Aitios® platform infers tissue of origin and characterizes tissue-specific biological changes from a routine blood draw at single-molecule resolution. The lead program applies the platform to preeclampsia risk stratification using first-trimester blood samples, with potential applications extending to earlier disease detection, patient stratification, and therapeutic response assessment across multiple conditions.

Don't miss Aitiologic's next move

Get an email the moment Aitiologic raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Aitiologic's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Aitiologic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.